Case report: Percoronary device closure of tortuous coronary artery fistula into left atrium.

Autor: Sun SB; Department of Cardiovascular Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Engineering Research Center for Heart Transplant and Material, Jinan, China., Kong Z; Department of Cardiovascular Surgery, Shandong Provincial Qianfoshan Hospital, Weifang Medical University, Weifang, China., Farhaj Z; Department of Cardiovascular Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Engineering Research Center for Heart Transplant and Material, Jinan, China., Hongxin L; Department of Cardiovascular Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Engineering Research Center for Heart Transplant and Material, Jinan, China.
Jazyk: angličtina
Zdroj: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Feb 14; Vol. 10, pp. 1106420. Date of Electronic Publication: 2023 Feb 14 (Print Publication: 2023).
DOI: 10.3389/fcvm.2023.1106420
Abstrakt: Surgical ligation and transcatheter occlusion are the mainstream for the treatment of coronary artery fistulas (CAFs). However, these techniques applied to tortuous and aneurysmal CAF, especially those draining into left-heart, have their known drawbacks. We report, a successful percoronary device closure of such CAF, originating from left main coronary artery and draining into left atrium, through a left subaxillary minithoracotomy. Through a puncture on the distal straight course, we occluded CAF exclusively under transesophageal echocardiography guidance. Complete occlusion was achieved. It's a simple, safe, and effective alternative for tortuous, large, and aneurysmal CAFs draining into the left heart.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Sun, Kong, Farhaj and Hongxin.)
Databáze: MEDLINE